Converting from Novolog 70/30 to Lantus: Dosing Strategy
For a patient taking Novolog 70/30 15 units 1-2 times daily (total daily dose 15-30 units), start Lantus at 8-12 units once daily, which represents approximately 80% of the basal component of the current premixed insulin regimen. 1, 2
Calculating the Starting Dose
The basal component of 70/30 insulin represents approximately 70% of the total daily dose 2:
- If taking 15 units once daily: Basal component = 10.5 units → Start Lantus at 8 units once daily (80% of basal component) 1, 2
- If taking 15 units twice daily (30 units total): Basal component = 21 units → Start Lantus at 12 units once daily (80% of basal component) 1, 2
The 20% reduction from the calculated basal component prevents hypoglycemia during the transition, particularly important given the variable dosing pattern 2.
Critical Gap: Loss of Prandial Coverage
This conversion creates a significant therapeutic gap because Novolog 70/30 provides both basal AND prandial insulin coverage, while Lantus provides only basal coverage. 2 The 30% rapid-acting component (4.5-9 units daily) will be lost in this transition.
Addressing the Prandial Gap
You have three options:
- Add rapid-acting insulin before meals: Start with 4 units of rapid-acting insulin (lispro, aspart, or glulisine) before the largest meal, or use 10% of the basal dose 1, 2
- Intermediate step: Add rapid-acting insulin before only the largest meal initially, then expand to other meals if needed 2
- Monitor closely: If the patient's A1C is near target and postprandial glucose remains acceptable, you may defer adding prandial insulin 2
Titration Protocol
Increase Lantus by 2 units every 3 days if fasting glucose is 140-179 mg/dL, or by 4 units every 3 days if fasting glucose is ≥180 mg/dL, targeting fasting glucose of 80-130 mg/dL. 1, 3
If hypoglycemia occurs without clear cause, reduce the dose by 10-20% immediately 1, 3
Critical Threshold Warning
When Lantus exceeds 0.5 units/kg/day (approximately 35-40 units for an average adult), stop escalating basal insulin and add prandial insulin instead. 1 Continuing to increase basal insulin beyond this threshold leads to "overbasalization" with increased hypoglycemia risk and suboptimal control 1.
Clinical signals of overbasalization include:
- Basal dose >0.5 units/kg/day
- Bedtime-to-morning glucose differential ≥50 mg/dL
- Hypoglycemia episodes
- High glucose variability 1
Monitoring Requirements
- Daily fasting blood glucose monitoring during titration 1, 3
- Pre-meal and 2-hour postprandial glucose if prandial insulin is added 1
- Reassess every 3 days during active titration 1
- Check HbA1c every 3 months to assess overall glycemic control 1
Common Pitfalls to Avoid
- Never use 1:1 unit conversion from total 70/30 dose to Lantus—this causes severe hypoglycemia 2
- Don't rely on sliding scale insulin alone as prandial replacement—this reactive approach leads to poor glycemic control 2
- Don't forget to continue metformin (unless contraindicated) when initiating basal insulin 1, 3
- Don't delay adding prandial insulin if postprandial glucose remains elevated or HbA1c stays above target after 3-6 months 1
Patient Education Essentials
Provide comprehensive education on: